Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

uBriGene / 宜明生物

Explore full profile

Beijing-rooted ATMP plasmid / AAV / LV / cell CRDMO

ChinaFounded 2015Biotech & Life Sciences
Valuation $500M–1B Last recorded · 2024
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for uBriGene / 宜明生物 and the history behind them.

About uBriGene / 宜明生物

Beijing-rooted ATMP CRDMO (uBriGene / 宜明生物) — plasmid, AAV/LV, cell-therapy and RNA GMP manufacturing across China + Maryland with 30+ IND assists. 宜明（北京）生物医药股份 group founded 2015 with Beijing/Suzhou/Jinan/Guangzhou and Maryland nodes; mid-size China CGT CDMO leftover beyond Hillgene·Genevoyager FIX / Mon OBiO·ProBio·Porton Advanced DNR.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
China
Employees
23
Open positions
1
Dealroom signal
47.7/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Genetics and genomics, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
b2c
Links
WebsiteLinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Dec 2024 $28M $550M Shunxi Private Equity Fund Management · Chang Development ↗
SERIES COther financing Apr 2023 $21M $138M Guotai Junan Innovation Investment · Economic Development Fund · Kejin New Kinetic Energy Fund · Fangfu Venture Capital ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

uBriGene / 宜明生物 website traffic

Latest recorded traffic for uBriGene / 宜明生物 is 4.3K monthly website visits, up 168.8% over the last three months. uBriGene / 宜明生物's team grew 4.5% over the past year.

Latest monthly visits4.3K 3-month web change+168.8% 1-year team growth+4.5%
Monthly website visitsNov 2022–Jul 2026
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
Warehouse and Facility SpecialistGermantown, MD · Logistics · Aug 15, 2026 Project Liaison Scientist - Bilingual (English & Chinese)Germantown, MD · Project Management · Aug 13, 2026 Application Scientist – Cell & Gene TherapyGermantown, MD · Other · Aug 6, 2026 Bilingual (English & Chinese) Project Coordinator/Manager - CDMO ServiceGermantown, MD · Project Management · Jul 25, 2026 Customer Support & Inside Sales Representative – Cell and Gene Therapy CRO ServicesGermantown, MD · C-Level · Jul 21, 2026
5 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Mitra bioNon-invasive diagnostics for skincare and therapeutics development London, United Kingdom Operational 16 $3M —
Genomes.ioSecure DNA sequencing, storage and sharing platform London, United Kingdom Operational
Senolytic TherapeuticsA discovery-stage biotech developing novel medicines that target senescent cells Barcelona, Spain Closed
HAYA TherapeuticsA pre-clinical biopharmaceutical company which is developing a first-in-class targeted therapy to treat heart failure Epalinges, Switzerland Operational
CoridonCoridon develops DNA therapies for the prevention and treatment of viral infections, and therapeutic vaccines for the treatment of cancer Brand, Austria Operational
CohbarCohBar Inc. – CohBar Inc. Menlo Park, United States Operational
Foldrx PharmaceuticalsFoldRx Pharmaceuticals is focused on discovering and developing disease-modifying drug therapies for protein misfolding diseases Cambridge, United States Acquired
Foundation MedicineTransformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease Boston, United States Acquired
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later13 investors entered at this stage

  • IDG Capital
  • Goldstone Investment
  • Huagai Capital
  • FOF Capital
  • Wenzhou Capital
  • Yuanchuang Capital
  • BGI Co-Win
  • Guotai Junan Innovation Investment
  • Economic Development Fund
  • Kejin New Kinetic Energy Fund
  • Fangfu Venture Capital
  • Shunxi Private Equity Fund Management
  • Chang Development

Talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States64.7%
🇨🇦 Canada23.5%
🇨🇳 China11.8%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about uBriGene / 宜明生物 on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See uBriGene / 宜明生物’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.